Company Overview and News
Pivotal Software, largely owned and controlled by Dell, will begin trading on the NYSE April 20. It aims to raise around $500 million by selling 33.1 million shares at $14-$16.
A month has gone by since the last earnings report for Oracle Corporation (ORCL - Free Report) . Shares have lost about 11.4% in that time frame.
I would like to know if it is looking at companies in regions such as India to add to its portfolio.
Fortinet's stock is trading at a 52-week high of $55.82 with a market cap of $9.4 billion.
Shares of Microsoft (MSFT - Free Report) popped over 2.2% on Tuesday to inch closer to their all-time high on the back of several significant announcements, including a Supreme Court ruling that ended a dispute between Microsoft and the U.S. Department of Justice.
Earlier this year, analysts expected Cloudera to die a slow death, driven by rising competition from established players.
Next month, when General Data Privacy Regulations (GDPR) take effect, there will be a seismic shift across many technology stocks reflecting a private data drought.
Subscription business Zuora IPO raised over $150 million last week, and the company has continued to stay at its elevated share price this week.
FireEye, Inc. (FEYE - Free Report) recently announced that it has enriched its cybersecurity solutions portfolio with FireEye Endpoint Security, FireEye Network Security, FireEye Email Security and FireEye Security Suite. Notably, FireEye, which is already a Gold level member of Oracle Partner Network (OPN), also enhanced its relationship with Oracle (ORCL - Free Report) . Having achieved the “Powered by Oracle Cloud” status, FireEye Email Security is now accessible via Oracle Cloud Marketplace, thus providing added security solutions for customers shifting to cloud.
Like much of Old Tech, IBM's Strategic Imperatives growth is being offset by the legacy biz/Services decline. If the legacy biz would just stabilize.
Oracle is looking at ways in which it can take on Amazon in the cloud space.
WASHINGTON: The U.S. Department of Defense on Monday updated its request for proposals from potential bidders on a US$10 billion project for cloud computing services, in a deal that has been closely watched because Amazon.com Inc has been considered to be a top contender.
WASHINGTON (Reuters) - The U.S. Department of Defense on Monday updated its request for proposals from potential bidders on a $10 billion project for cloud computing services, in a deal that has been closely watched because Amazon.com Inc (AMZN.O) has been considered to be a top contender.
During the past few months, Cisco Systems, Inc. (NASDAQ:CSCO) certainly has been volatile, a has much of the tech sector. Just take a look at the charts for big-names like Facebook, Inc. (NASDAQ:FB), Amazon.com, Inc. (NASDAQ:AMZN) and Oracle Corporation (NYSE:ORCL). Yet Cisco stock has still been able to manage through all this fairly well.
Oracle Corp co-CEO Safra Catz said on Monday she expected an acceleration in the company's cloud business after the software maker last month reported sales from this business that fell short of Wall Street forecasts.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET